Atossa Genetics Inc. (ATOS) Social Stream
Atossa Therapeutics Inc (ATOS) Price Targets From Analysts
Use the tables below to see what analysts covering Atossa Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued June 25, 2021
The Trend in the Analyst Price Target
ATOS's average price target has moved up $0.25 over the prior 65 days.
ATOS reports an average of 112.54% for its upside potential over the past 170 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ATOS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATOS as an investment opportunity.
- ATOS has a greater number of analysts covering the stock than practically none of all US stocks.
- Atossa Therapeutics Inc's variance in analysts' estimates is lower than just about 100% of all US stocks.
- Atossa Therapeutics Inc's average analyst price target is higher than 10.08% of Healthcare stocks.
- Atossa Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 86.47% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Atossa Therapeutics Inc are ATNX, ATNM, and ATNF.
Make investment decisions regarding ATOS using the data that counts. Try POWR Ratings for free.